Page last updated: 2024-11-08

biguanides and Leukemia

biguanides has been researched along with Leukemia in 1 studies

Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sharon, A1
Berdicevsky, I1
Ben-Aryeh, H1
Gutman, D1

Other Studies

1 other study available for biguanides and Leukemia

ArticleYear
The effect of chlorhexidine mouth rinses on oral Candida in a group of leukemic patients.
    Oral surgery, oral medicine, and oral pathology, 1977, Volume: 44, Issue:2

    Topics: Biguanides; Candida albicans; Chlorhexidine; Chronic Disease; Humans; Leukemia; Mouth; Mouthwashes;

1977